| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1316231 | 6480464 | Ethinyl Estradiol affects the expression of NFKB2 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:1316230 | 6480464 | Estradiol results in increased expression of NFKB2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1316231 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[Lipopolysaccharides binds to and results in increased activity of TLR4 protein] which results in increased activity of NFKB2 protein] | CTD | PMID:21097750 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1316231 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFKB2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFKB2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1316231 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NFKB2 promoter] | CTD | PMID:19654925 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of NFKB2 mRNA | CTD | PMID:21346803 |
| acetaldehyde | multiple interactions | ISO | RGD:1316230 | 6480464 | Acetaldehyde results in increased activity of [NFKBIA protein binds to NFKB2 protein] | CTD | PMID:10799556 |
| asbestos | increases expression | ISO | RGD:1316230 | 6480464 | Asbestos results in increased expression of NFKB2 mRNA | CTD | PMID:22398240 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1316231 | 6480464 | Benzo(a)pyrene results in decreased expression of NFKB2 mRNA | CTD | PMID:19770486 |
| cadmium atom | multiple interactions | ISO | RGD:1316230 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of NFKB2 mRNA | CTD | PMID:21481475 |
| cadmium selenide | multiple interactions | ISO | RGD:1316230 | 6480464 | [cadmium selenide co-treated with zinc sulfide] results in increased expression of NFKB2 mRNA | CTD | PMID:22342292 |
| cerium trichloride | increases expression | ISO | RGD:1316231 | 6480464 | cerous chloride results in increased expression of NFKB2 protein; more ... | CTD | PMID:21656643 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of NFKB2 mRNA | CTD | PMID:20187946 |
| curcumin | decreases activity | ISO | RGD:1316230 | 6480464 | Curcumin results in decreased activity of NFKB2 protein | CTD | PMID:16173963 |
| cyclosporin A | increases expression | ISO | RGD:1316230 | 6480464 | Cyclosporine results in increased expression of NFKB2 mRNA | CTD | PMID:20106945 |
| dexamethasone | increases expression | ISO | RGD:1316230 | 6480464 | Dexamethasone results in increased expression of NFKB2 mRNA | CTD | PMID:19022236 |
| diarsenic trioxide | decreases expression | ISO | RGD:1316230 | 6480464 | arsenic trioxide results in decreased expression of NFKB2 protein | CTD | PMID:18349030 |
| dibutyl phthalate | increases expression | ISO | RGD:1316231 | 6480464 | Dibutyl Phthalate results in increased expression of NFKB2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1316231 | 6480464 | Dibutyl Phthalate results in increased expression of NFKB2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NFKB2 mRNA | CTD | PMID:21266533 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1316230 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [IL1B protein results in increased expression of NFKB2 mRNA] | CTD | PMID:21878375 |
| doxorubicin | affects response to substance | ISO | RGD:1316230 | 6480464 | NFKB2 protein affects the susceptibility to Doxorubicin | CTD | PMID:17890907 |
| elemental selenium | multiple interactions | ISO | RGD:1316230 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of NFKB2 mRNA | CTD | PMID:21481475 |
| ellagic acid | decreases expression | ISO | RGD:1316230 | 6480464 | Ellagic Acid results in decreased expression of NFKB2 mRNA | CTD | PMID:12002526 |
| ethanol | multiple interactions | ISO | RGD:1316230 | 6480464 | Ethanol results in increased activity of [NFKB2 protein binds to NFKB1 protein] | CTD | PMID:10573527 |
| genistein | multiple interactions | ISO | RGD:1316230 | 6480464 | ESR2 promotes the reaction [Genistein results in decreased expression of NFKB2 protein] | CTD | PMID:20884965 |
| genistein | decreases expression | ISO | RGD:1316230 | 6480464 | Genistein results in decreased expression of NFKB2 protein | CTD | PMID:20884965 |
| methotrexate | affects response to substance | ISO | RGD:1316230 | 6480464 | NFKB2 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 |
| methoxychlor | affects expression | ISO | RGD:1316231 | 6480464 | Methoxychlor affects the expression of NFKB2 mRNA | CTD | PMID:20829426 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of NFKB2 mRNA | CTD | PMID:16809437 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1316231 | 6480464 | Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFKB2 protein]] | CTD | PMID:19642688 |
| nickel dichloride | increases expression | ISO | RGD:1316230 | 6480464 | nickel chloride results in increased expression of NFKB2 mRNA | CTD | PMID:17312168 |
| paracetamol | affects expression | ISO | RGD:1316231 | 6480464 | Acetaminophen affects the expression of NFKB2 mRNA | CTD | PMID:17562736 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:1316231 | 6480464 | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of NFKB2 mRNA] | CTD | PMID:20423518 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of NFKB2 mRNA | CTD | PMID:22037397 |
| pirinixic acid | decreases expression | ISO | RGD:1316231 | 6480464 | pirinixic acid results in decreased expression of NFKB2 mRNA | CTD | PMID:18249437 PMID:17426115 |
| pirinixic acid | decreases expression | ISO | RGD:1316231 | 6480464 | pirinixic acid results in decreased expression of NFKB2 mRNA | CTD | PMID:17426115 PMID:18249437 |
| quercetin | increases expression | ISO | RGD:1316230 | 6480464 | Quercetin results in increased expression of NFKB2 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1316230 | 6480464 | [resveratrol co-treated with beta-1,3-glucan] results in increased expression of NFKB2 mRNA | CTD | PMID:17690738 |
| resveratrol | decreases expression | ISO | RGD:1316230 | 6480464 | resveratrol results in decreased expression of NFKB2 mRNA | CTD | PMID:12002526 |
| selenium atom | multiple interactions | ISO | RGD:1316230 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of NFKB2 mRNA | CTD | PMID:21481475 |
| silver atom | decreases expression | ISO | RGD:1316230 | 6480464 | Silver results in decreased expression of NFKB2 mRNA | CTD | PMID:22342292 |
| silver(0) | decreases expression | ISO | RGD:1316230 | 6480464 | Silver results in decreased expression of NFKB2 mRNA | CTD | PMID:22342292 |
| succimer | multiple interactions | ISO | RGD:1316231 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB2 mRNA | CTD | PMID:21641980 |
| titanium dioxide | increases expression | ISO | RGD:1316230 | 6480464 | titanium dioxide results in increased expression of NFKB2 mRNA | CTD | PMID:22342292 |
| trans-resveratrol | multiple interactions | ISO | RGD:1316230 | 6480464 | [resveratrol co-treated with beta-1,3-glucan] results in increased expression of NFKB2 mRNA | CTD | PMID:17690738 |
| trans-resveratrol | decreases expression | ISO | RGD:1316230 | 6480464 | resveratrol results in decreased expression of NFKB2 mRNA | CTD | PMID:12002526 |
| trichloroethene | increases expression | ISO | RGD:1316231 | 6480464 | Trichloroethylene results in increased expression of NFKB2 mRNA | CTD | PMID:18565563 PMID:20709644 |
| trichloroethene | increases expression | ISO | RGD:1316231 | 6480464 | Trichloroethylene results in increased expression of NFKB2 protein | CTD | PMID:20709644 |
| trichloroethene | increases expression | ISO | RGD:1316231 | 6480464 | Trichloroethylene results in increased expression of NFKB2 mRNA | CTD | PMID:20709644 PMID:18565563 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of NFKB2 mRNA | CTD | PMID:21515302 |
| zinc atom | increases expression | ISO | RGD:1316230 | 6480464 | Zinc deficiency results in increased expression of NFKB2 mRNA | CTD | PMID:22171008 |
| zinc atom | decreases expression | ISO | RGD:1316230 | 6480464 | Zinc deficiency results in decreased expression of NFKB2 mRNA | CTD | PMID:18356318 |
| zinc(0) | increases expression | ISO | RGD:1316230 | 6480464 | Zinc deficiency results in increased expression of NFKB2 mRNA | CTD | PMID:22171008 |
| zinc(0) | decreases expression | ISO | RGD:1316230 | 6480464 | Zinc deficiency results in decreased expression of NFKB2 mRNA | CTD | PMID:18356318 |